Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early IV amino acids in traumatic injury
NCT02837861Phase 1Completed
- Sponsor
- Boston Medical Center
- Start
- Mar 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of l-leucine in traumatic injury (2 arms), sponsored by Boston Medical Center. Primary endpoint: Nitrogen balance and Catabolic Index at 8 days. Started Mar 2017; status: completed.
02
Drugs
l-leucine
03
Conditions
traumatic injury
Beyond the preview
Go deeper on NCT02837861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02837861.